Qu'apporte au clinicien le dosage ultra-sensible du PSA? Tentative de réponse à propos de 168 patients

Armbruster, 1993, PSA: biochemistry, analytical methods and clinical applications, Clin Chem, 39/2, 181, 10.1093/clinchem/39.2.181 Basuyau, 1988, Dosage du PSA: comparaison des techniques de dosage RIA et EIA, ISB, 6, 469 Baud, 1989, Évaluation de la limite de détection, ISB, 15, 157 Beaudonnet, 1993, Évaluation analytique du dosage du PSA sur système IMX Abbott, Immunoanal Biol Spéc, 8, 253 Dnistrian, 1992, Abbott IMX evaluated for assay of PSA in serum, Clin Chem, 38, 2140, 10.1093/clinchem/38.10.2140 Frazier, 1993, Is PSA of clinical importance in evaluating outcome after radical prostatectomy?, J Urol, 149, 516, 10.1016/S0022-5347(17)36132-3 Graves, 1990, Comparison of a polyclonal and monoclonal immuno assay for PSA: need for an international antigen standard, J Urol, 144, 1516, 10.1016/S0022-5347(17)39789-6 Graves, 1992, Ultra-sensible radioimmunoassay for PSA, Clin Chem, 38, 735, 10.1093/clinchem/38.5.735 Hortin, 1988, Differences in values obtained with two assays of PSA, J Urol, 139, 762, 10.1016/S0022-5347(17)42627-9 Lange, 1989, The value of serum PSA determination before and after radical prostatectomy, J Urol, 141, 873, 10.1016/S0022-5347(17)41037-8 Stamey, 1993, Early detection of residual prostate cancer after radical prostatectomy by an ultra sensitive assay for PSA, J Urol, 149, 787, 10.1016/S0022-5347(17)36208-0 Vessela, 1992, Evaluation of the Abbott IMX automated immunoassay of PSA, Clin Chem, 38, 2044, 10.1093/clinchem/38.10.2044